- Home
- LAKE vs IBIO Comparison
LAKE vs IBIO Comparison
Compare LAKE & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAKE | IBIO |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.1M | 72.2M |
| IPO Year | 2013 | 2009 |
Fundamental Metrics
Financial Performance| Metric | LAKE | IBIO |
|---|---|---|
| Price | $9.08 | $2.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $16.33 | $4.75 |
| AVG Volume (30 Days) | 79.3K | ★ 932.6K |
| Earning Date | 04-16-2026 | 05-01-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ 73.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,211,000.00 | N/A |
| Revenue This Year | $19.75 | N/A |
| Revenue Next Year | $6.94 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2554.14 | N/A |
| 52 Week Low | $7.15 | $0.56 |
| 52 Week High | $20.50 | $3.82 |
Technical Indicators
Market Signals| Indicator | LAKE | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 48.37 |
| Support Level | $8.70 | $2.02 |
| Resistance Level | $9.67 | $2.82 |
| Average True Range (ATR) | 0.44 | 0.19 |
| MACD | 0.16 | 0.00 |
| Stochastic Oscillator | 99.49 | 64.61 |
Price Performance
Historical ComparisonAbout LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.